Search Page

1

Cite

Share

Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.

Hodgkins P, Sasané R, Meijer WM. Hodgkins P, et al. Clin Ther. 2011 Feb;33(2):188-203. doi: 10.1016/j.clinthera.2011.03.001. Clin Ther. 2011. PMID: 21497704

Cite

Share

2

Cite

Share

Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.

Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. Weiss MD, et al. J Clin Psychiatry. 2010 Apr;71(4):381-90. doi: 10.4088/JCP.08m04709pur. Epub 2010 Feb 23. J Clin Psychiatry. 2010. PMID: 20361900

Cite

Share

3

Cite

Share

Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.

Signorovitch J, Erder MH, Xie J, Sikirica V, Lu M, Hodgkins PS, Wu EQ. Signorovitch J, et al. Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:130-7. doi: 10.1002/pds.3246. Pharmacoepidemiol Drug Saf. 2012. PMID: 22552988

Cite

Share

4

Cite

Share

Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.

Lachaine J, Beauchemin C, Sasane R, Hodgkins PS. Lachaine J, et al. Postgrad Med. 2012 May;124(3):139-48. doi: 10.3810/pgm.2012.05.2557. Postgrad Med. 2012. PMID: 22691908

Cite

Share

5

Cite

Share

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system.

Young S, González RA, Fridman M, Hodgkins P, Kim K, Gudjonsson GH. Young S, et al. Among authors: hodgkins p. BMC Psychiatry. 2018 Jun 25;18(1):210. doi: 10.1186/s12888-018-1792-x. BMC Psychiatry. 2018. PMID: 29940897 Free PMC article.

Cite

Share

6

Cite

Share

Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury.

Young S, González RA, Fridman M, Hodgkins P, Kim K, Gudjonsson GH. Young S, et al. Among authors: hodgkins p. BMC Psychiatry. 2018 Jun 22;18(1):209. doi: 10.1186/s12888-018-1785-9. BMC Psychiatry. 2018. PMID: 29929487 Free PMC article.

Cite

Share

7

Cite

Share

Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.

Lachaine J, De G, Sikirica V, Van Stralen J, Hodgkins P, Yang H, Heroux J, Ben Amor L. Lachaine J, et al. Among authors: hodgkins p. Can J Psychiatry. 2014 Nov;59(11):597-608. doi: 10.1177/070674371405901106. Can J Psychiatry. 2014. PMID: 25565476 Free PMC article.

Cite

Share

8

Cite

Share

Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Banaschewski T, Johnson M, Lecendreux M, Zuddas A, Adeyi B, Hodgkins P, Squires LA, Coghill DR. Banaschewski T, et al. Among authors: hodgkins p. CNS Drugs. 2014 Dec;28(12):1191-203. doi: 10.1007/s40263-014-0193-z. CNS Drugs. 2014. PMID: 25139785 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.

Betts KA, Sikirica V, Hodgkins P, Zhou Z, Xie J, DeLeon A, Erder MH, Wu EQ. Betts KA, et al. Among authors: hodgkins p. J Child Adolesc Psychopharmacol. 2014 Jun;24(5):260-8. doi: 10.1089/cap.2013.0107. Epub 2014 May 19. J Child Adolesc Psychopharmacol. 2014. PMID: 24839998

Cite

Share

10

Cite

Share

Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.

Banaschewski T, Soutullo C, Lecendreux M, Johnson M, Zuddas A, Hodgkins P, Adeyi B, Squires LA, Coghill D. Banaschewski T, et al. Among authors: hodgkins p. CNS Drugs. 2013 Oct;27(10):829-40. doi: 10.1007/s40263-013-0095-5. CNS Drugs. 2013. PMID: 23893527 Free PMC article. Clinical Trial.

Cite

Share